Akynzeo 300mg/0.5mg hard capsules

  • Name:

    Akynzeo 300mg/0.5mg hard capsules

  • Company:
    info
  • Active Ingredients:

    Netupitant, Palonosetron hydrochloride

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/02/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 10/2/2020

Click on this link to Download PDF directly

Chugai Pharma UK Limited

Chugai Pharma UK Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Akynzeo 300mg/0.5mg hard capsules Active Ingredients Netupitant, Palonosetron hydrochloride
1 - 0 of 1 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 10 February 2020

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 6.5 - Nature and contents of container
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
  • Removal of Black Inverted Triangle

Updated on 10 February 2020 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - excipient warnings
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Removal of Black Inverted Triangle

Updated on 6 October 2017 SPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

In section 6.5 (nature and contents of container) a 4 capsule pack has been added.

In section 8 (marketing authorisation numbers) a new marketing authorisation number has been added.

In section 10 (date of revision of the text) the date has been revised to 21/09/2017.

Updated on 6 October 2017

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 5 October 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 5 October 2017 PIL

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 3 May 2017 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 26 August 2016 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

In section 6.3, the shelf-life has been changed from 3 to 4 years
In section 10, the date of revision of the text has been changed to 16/06/2016.

Updated on 2 December 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 2 December 2015 SPC

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

In section 5.1, minor corrections to HEC study data.

Updated on 20 August 2015 SPC

Reasons for updating

  • New SPC for new product
  • SPC submitted in error

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided